CALCA and migraine disorder: There is evidence that NO can directly increase CGRP release via the TRPV1 receptor [81], although clinical trial evidence does not support a role for TRPV1 blockade in migraine [82], and CGRP may cause vasodilatation via NO mechanisms [83].